Advances in Multiple Sclerosis
- In MS, Brain Atrophy is Associated With Disease Progression Independent of Relapse Activity
- MS-Related Optic Neuritis: Is This a New Diagnostic Era?
- A Closer Look at MS Risk in Patients Taking Anti-TNFα Agents
- In MS Patients, Sleep Affects Cognitive Function in Expected—and Unexpected—Ways
- Is sGFAP a Dynamic New Biomarker for Disease Progression in MS?
- Multiple Sclerosis, DMTs, and the Role of Specialty Pharmacists
- MS and Race: Does Prevalence Differ Between Groups?
- Helping Patients with Multiple Sclerosis Steer a Stable Financial Course
- In Patients with MS, Fatigue Slams Quality of Life
- "I’ve Been Diagnosed with MS. Should I Tell Anyone?"
- Emotional Recognition in Multiple Sclerosis
- Cessation of Disease-modifying Therapy in Patients with MS
- Assessing Early MS Treatment Response with Repeat Scans
- MS and Family Planning
- What’s Different about the MS Experience in Black and Hispanic Patients?
- “I Have MS.” “But You Look So Good!”
- MS: The Possible Family Fallout
- Compassion, Health Literacy, and Bypassing Dr. Google
- Familial MS
- When Clinical MS Manifestations Don’t Reflect What’s Happening in the Brain